Anti-malaria vaccine uses attenuated malaria parasites

07/2/2013 | Yahoo

Researchers have developed an anti-malaria vaccine that uses blood-stage malaria parasites that were modified with a chemical agent to prevent replication. Mice injected with the vaccine showed immunity to a variety of malaria species for more than 100 days, according to the study published in the Journal of Clinical Investigation.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC